Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Advanced Lung Cancer
Clinical trial NCT03944980 · UNKNOWN
Trial details
- NCT number
- NCT03944980
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-01
- Primary completion
- 2021-06-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.